Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability

被引:94
作者
Kimura, T
Shuto, D
Hamada, Y
Igawa, N
Kasai, S
Liu, P
Hidaka, K
Hamada, T
Hayashi, Y
Kiso, Y [1 ]
机构
[1] Kyoto Pharmaceut Univ, Ctr Frontier Res Med Sci, Dept Med Chem, Yamashima Ku, Kyoto 6078412, Japan
[2] Kyoto Pharmaceut Univ, Century COE Program 21st, Yamashima Ku, Kyoto 6078412, Japan
关键词
Alzheimer's disease; BACE1; inhibitor; beta-secretase; bioisostere;
D O I
10.1016/j.bmcl.2004.09.090
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recently, we reported potent and small-sized BACE1 inhibitors KMI-358 and KMI-370 in which the Glu residue is replaced by a beta-N-oxalyl-DAP (L-alpha,beta-diaminopropionyl) residue at the P-4 position. The beta-N-oxalyl-DAP group is important for enhancing BACE1 inhibitory activity, but these inhibitors isomerized to alpha-N-oxalyl-DAP derivatives in solvents. Hence, we used a tetrazole moiety as a bioisostere of the free carboxylic acid of the oxalyl group. KMI-420 and KMI-429, containing a tetrazole ring, showed improved stability and potent enzyme inhibitory activity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 30 条
[21]   KMI-008, a novel β-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic:: Design and synthesis of substrate-based octapeptides [J].
Shuto, D ;
Kasai, S ;
Kimura, T ;
Liu, P ;
Hidaka, K ;
Hamada, T ;
Shibakawa, S ;
Hayashi, Y ;
Hattori, C ;
Szabo, B ;
Ishiura, S ;
Kiso, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4273-4276
[22]   Purification and cloning of amyloid precursor protein β-secretase from human brain [J].
Sinha, S ;
Anderson, JP ;
Barbour, R ;
Basi, GS ;
Caccavello, R ;
Davis, D ;
Doan, M ;
Dovey, HF ;
Frigon, N ;
Hong, J ;
Jacobson-Croak, K ;
Jewett, N ;
Keim, P ;
Knops, J ;
Lieberburg, I ;
Power, M ;
Tan, H ;
Tatsuno, G ;
Tung, J ;
Schenk, D ;
Seubert, P ;
Suomensaari, SM ;
Wang, SW ;
Walker, D ;
Zhao, J ;
McConlogue, L ;
John, V .
NATURE, 1999, 402 (6761) :537-540
[23]   Cellular mechanisms of β-amyloid production and secretion [J].
Sinha, S ;
Lieberburg, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11049-11053
[24]   AMYLOIDOSIS [J].
SIPE, JD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :947-975
[25]   LATHYRISM - EVIDENCE FOR ROLE OF THE NEUROEXCITATORY AMINO-ACID BOAA [J].
SPENCER, PS ;
LUDOLPH, A ;
DWIVEDI, MP ;
ROY, DN ;
HUGON, J ;
SCHAUMBURG, HH .
LANCET, 1986, 2 (8515) :1066-1067
[26]   Genes and mechanisms involved in β-amyloid generation and Alzheimer's disease [J].
Steiner, H ;
Capell, A ;
Leimer, U ;
Haass, C .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (06) :266-270
[27]   Synthesis of potent β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies [J].
Tamamura, H ;
Kato, T ;
Otaka, A ;
Fujii, N .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (14) :2468-2473
[28]   Design of substrate-based inhibitors of human β-secretase [J].
Tung, JS ;
Davis, DL ;
Anderson, JP ;
Walker, DE ;
Mamo, S ;
Jewett, N ;
Hom, RK ;
Sinha, S ;
Thorsett, ED ;
John, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :259-262
[29]   β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE [J].
Vassar, R ;
Bennett, BD ;
Babu-Khan, S ;
Kahn, S ;
Mendiaz, EA ;
Denis, P ;
Teplow, DB ;
Ross, S ;
Amarante, P ;
Loeloff, R ;
Luo, Y ;
Fisher, S ;
Fuller, L ;
Edenson, S ;
Lile, J ;
Jarosinski, MA ;
Biere, AL ;
Curran, E ;
Burgess, T ;
Louis, JC ;
Collins, F ;
Treanor, J ;
Rogers, G ;
Citron, M .
SCIENCE, 1999, 286 (5440) :735-741
[30]   Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity [J].
Yan, RQ ;
Bienkowski, MJ ;
Shuck, ME ;
Miao, HY ;
Tory, MC ;
Pauley, AM ;
Brashler, JR ;
Stratman, NC ;
Mathews, WR ;
Buhl, AE ;
Carter, DB ;
Tomasselli, AG ;
Parodi, LA ;
Heinrikson, RL ;
Gurney, ME .
NATURE, 1999, 402 (6761) :533-537